Traphagen Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $970K | Sell |
1,244
-27
| -2% | -$21K | 0.09% | 74 |
|
|
2025
Q1 | $1.05M | Sell |
1,271
-3
| -0.2% | -$2.48K | 0.11% | 67 |
|
|
2024
Q4 | $984K | Sell |
1,274
-5
| -0.4% | -$3.86K | 0.1% | 71 |
|
|
2024
Q3 | $1.13M | Buy |
1,279
+14
| +1% | +$12.4K | 0.11% | 63 |
|
|
2024
Q2 | $1.15M | Sell |
1,265
-341
| -21% | -$309K | 0.12% | 62 |
|
|
2024
Q1 | $1.25M | Buy |
1,606
+83
| +5% | +$64.6K | 0.13% | 59 |
|
|
2023
Q4 | $888K | Buy |
1,523
+109
| +8% | +$63.6K | 0.1% | 65 |
|
|
2023
Q3 | $759K | Sell |
1,414
-44
| -3% | -$23.6K | 0.1% | 67 |
|
|
2023
Q2 | $684K | Buy |
1,458
+277
| +23% | +$130K | 0.09% | 71 |
|
|
2023
Q1 | $405K | Buy |
1,181
+42
| +4% | +$14.4K | 0.06% | 99 |
|
|
2022
Q4 | $417K | Buy |
1,139
+496
| +77% | +$181K | 0.07% | 90 |
|
|
2022
Q3 | $208K | Sell |
643
-7,426
| -92% | -$2.4M | 0.04% | 131 |
|
|
2022
Q2 | $691K | Sell |
8,069
-506
| -6% | -$43.3K | 0.13% | 57 |
|
|
2022
Q1 | $708K | Sell |
8,575
-366
| -4% | -$30.2K | 0.11% | 55 |
|
|
2021
Q4 | $547K | Buy |
8,941
+677
| +8% | +$41.4K | 0.09% | 70 |
|
|
2021
Q3 | $486K | Buy |
8,264
+180
| +2% | +$10.6K | 0.09% | 71 |
|
|
2021
Q2 | $510K | Sell |
8,084
-89
| -1% | -$5.61K | 0.09% | 75 |
|
|
2021
Q1 | $456K | Sell |
8,173
-71
| -0.9% | -$3.96K | 0.08% | 82 |
|
|
2020
Q4 | $340K | Buy |
8,244
+2,844
| +53% | +$117K | 0.06% | 93 |
|
|
2020
Q3 | $243K | Buy |
+5,400
| New | +$243K | 0.05% | 105 |
|